Paolo Gontero

Research interests

Publications

• European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update

  European Urology · 2024 · 10.1016/j.eururo.2024.07.027

• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

  European Urology · 2023 · https://doi.org/10.1016/j.eururo.2023.03.013

• European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel

  European Urology · 2021 · 10.1016/j.eururo.2020.12.033

• European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

  European Urology · 2021 · https://doi.org/10.1016/j.eururo.2021.08.010

• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

  European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.05.042

• EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

  European Urology · 2019 · 10.1016/j.eururo.2019.09.035

• EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

  Annals of Oncology · 2019 · 10.1093/annonc/mdz296

• European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.08.016

• Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”

  European Urology Focus · 2018 · 10.1016/j.euf.2018.01.003

• Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review

  European Urology · 2018 · 10.1016/j.eururo.2018.02.014

• Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review

  European Urology Focus · 2017 · 10.1016/j.euf.2017.10.003

• Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review

  European Urology · 2017 · 10.1016/j.eururo.2017.04.015

• The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury

  Stem Cell Research & Therapy · 2017 · 10.1186/s13287-017-0478-5

• European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

  European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.07.036

• EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

  European Urology · 2015 · 10.1016/j.eururo.2015.06.045

• Prognostic Factors and Risk Groups in T1G3 Non–Muscle-invasive Bladder Cancer Patients Initially Treated with Bacillus Calmette-Guérin: Results of a Retrospective Multicenter Study of 2451 Patients

  European Urology · 2014 · 10.1016/j.eururo.2014.06.040

• Stratification of High-risk Prostate Cancer into Prognostic Categories: A European Multi-institutional Study

  European Urology · 2014 · 10.1016/j.eururo.2014.01.020

• The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia ( BPH )

  British Journal of Urology · 2013 · 10.1111/bju.12118

• Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG

  European Urology · 2013 · 10.1016/j.eururo.2013.07.021

• Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance

  European Urology · 2012 · 10.1016/j.eururo.2012.10.039

• The Role of Bacillus Calmette-Guérin in the Treatment of Non–Muscle-Invasive Bladder Cancer

  European Urology · 2009 · 10.1016/j.eururo.2009.11.023

• An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

  European Journal of Cancer · 2008 · 10.1016/j.ejca.2008.07.030

• Prevalence, Incidence Estimation, Risk Factors and Characterization of Chronic Prostatitis/Chronic Pelvic Pain Syndrome in Urological Hospital Outpatients in Italy: Results of a Multicenter Case-Control Observational Study

  The Journal of Urology · 2007 · 10.1016/j.juro.2007.08.046

• Finasteride 5 mg and Sexual Side Effects: How Many of these are Related to a Nocebo Phenomenon?

  The Journal of Sexual Medicine · 2007 · 10.1111/j.1743-6109.2007.00563.x

• Penile length is normal in most men seeking penile lengthening procedures

  International Journal of Impotence Research · 2002 · 10.1038/sj.ijir.3900887

Current projects

No projects listed.